These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35909886)

  • 1. RUNX3-Regulated GALNT6 Promotes the Migration and Invasion of Hepatocellular Carcinoma Cells by Mediating O-Glycosylation of MUC1.
    Gao F; Zheng G
    Dis Markers; 2022; 2022():2959846. PubMed ID: 35909886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical roles of mucin 1 glycosylation by transactivated polypeptide N-acetylgalactosaminyltransferase 6 in mammary carcinogenesis.
    Park JH; Nishidate T; Kijima K; Ohashi T; Takegawa K; Fujikane T; Hirata K; Nakamura Y; Katagiri T
    Cancer Res; 2010 Apr; 70(7):2759-69. PubMed ID: 20215525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GALNT6 Promotes Tumorigenicity and Metastasis of Breast Cancer Cell via β-catenin/MUC1-C Signaling Pathway.
    Mao Y; Zhang Y; Fan S; Chen L; Tang L; Chen X; Lyu J
    Int J Biol Sci; 2019; 15(1):169-182. PubMed ID: 30662357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-acetylgalactosaminyltransferase GALNT6 is a potential therapeutic target of clear cell renal cell carcinoma progression.
    Sun L; Li Z; Shu P; Lu M
    Cancer Sci; 2024 Oct; 115(10):3320-3332. PubMed ID: 39105355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucin glycosylating enzyme GALNT2 regulates the malignant character of hepatocellular carcinoma by modifying the EGF receptor.
    Wu YM; Liu CH; Hu RH; Huang MJ; Lee JJ; Chen CH; Huang J; Lai HS; Lee PH; Hsu WM; Huang HC; Huang MC
    Cancer Res; 2011 Dec; 71(23):7270-9. PubMed ID: 21990321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of GALNT1 suppresses malignant phenotype of hepatocellular carcinoma by suppressing EGFR signaling.
    Huang MJ; Hu RH; Chou CH; Hsu CL; Liu YW; Huang J; Hung JS; Lai IR; Juan HF; Yu SL; Wu YM; Huang MC
    Oncotarget; 2015 Mar; 6(8):5650-65. PubMed ID: 25730904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-20a-5p regulates the epithelial-mesenchymal transition of human hepatocellular carcinoma by targeting RUNX3.
    Wang X; Wei P; Yang L; Liu F; Tong X; Yang X; Su L
    Chin Med J (Engl); 2022 Sep; 135(17):2089-2097. PubMed ID: 35143426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. microRNA-802 accelerates hepatocellular carcinoma growth by targeting RUNX3.
    Ni M; Zhao Y; Zhang WJ; Jiang YJ; Fu H; Huang F; Li DJ; Shen FM
    J Cell Physiol; 2020 Oct; 235(10):7128-7135. PubMed ID: 32003017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical Role of Estrogen Receptor Alpha O-Glycosylation by N-Acetylgalactosaminyltransferase 6 (GALNT6) in Its Nuclear Localization in Breast Cancer Cells.
    Deng B; Tarhan YE; Ueda K; Ren L; Katagiri T; Park JH; Nakamura Y
    Neoplasia; 2018 Oct; 20(10):1038-1044. PubMed ID: 30208353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The polypeptide GALNT6 Displays Redundant Functions upon Suppression of its Closest Homolog GALNT3 in Mediating Aberrant O-Glycosylation, Associated with Ovarian Cancer Progression.
    Sheta R; Bachvarova M; Macdonald E; Gobeil S; Vanderhyden B; Bachvarov D
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31071912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GALNT6 promotes breast cancer metastasis by increasing mucin-type O-glycosylation of α2M.
    Liu C; Li Z; Xu L; Shi Y; Zhang X; Shi S; Hou K; Fan Y; Li C; Wang X; Zhou L; Liu Y; Qu X; Che X
    Aging (Albany NY); 2020 Jun; 12(12):11794-11811. PubMed ID: 32559179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of OGT by Caveolin-1 promotes hepatocellular carcinoma cell migration and invasion.
    Wang L; Feng Y; Zhang C; Chen X; Huang H; Li W; Zhang J; Liu Y
    Cell Biol Int; 2021 Nov; 45(11):2251-2263. PubMed ID: 34288245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-20a-5p targets RUNX3 to regulate proliferation and migration of human hepatocellular cancer cells.
    Chen Y; Wang X; Cheng J; Wang Z; Jiang T; Hou N; Liu N; Song T; Huang C
    Oncol Rep; 2016 Dec; 36(6):3379-3386. PubMed ID: 27748919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA CRNDE promotes the proliferation, migration and invasion of hepatocellular carcinoma cells through miR-217/MAPK1 axis.
    Wang H; Ke J; Guo Q; Barnabo Nampoukime KP; Yang P; Ma K
    J Cell Mol Med; 2018 Dec; 22(12):5862-5876. PubMed ID: 30246921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcription factor specificity protein 1-mediated Serine/threonine kinase 39 upregulation promotes the proliferation, migration, invasion and epithelial-mesenchymal transition of hepatocellular carcinoma cells by activating the transforming growth factor-β1 /Smad2/3 pathway.
    Wang J; Fan Z; Li J; Yang J; Liu X; Cheng J
    Bioengineered; 2021 Dec; 12(1):3566-3577. PubMed ID: 34281492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GALNT6 Stabilizes GRP78 Protein by O-glycosylation and Enhances its Activity to Suppress Apoptosis Under Stress Condition.
    Lin J; Chung S; Ueda K; Matsuda K; Nakamura Y; Park JH
    Neoplasia; 2017 Jan; 19(1):43-53. PubMed ID: 28110670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Runt-related transcription factor 3 reverses epithelial-mesenchymal transition in hepatocellular carcinoma.
    Tanaka S; Shiraha H; Nakanishi Y; Nishina S; Matsubara M; Horiguchi S; Takaoka N; Iwamuro M; Kataoka J; Kuwaki K; Hagihara H; Toshimori J; Ohnishi H; Takaki A; Nakamura S; Nouso K; Yagi T; Yamamoto K
    Int J Cancer; 2012 Dec; 131(11):2537-46. PubMed ID: 22488108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of runt-related transcription factor 3 expression leads hepatocellular carcinoma cells to escape apoptosis.
    Nakanishi Y; Shiraha H; Nishina S; Tanaka S; Matsubara M; Horiguchi S; Iwamuro M; Takaoka N; Uemura M; Kuwaki K; Hagihara H; Toshimori J; Ohnishi H; Takaki A; Nakamura S; Kobayashi Y; Nouso K; Yagi T; Yamamoto K
    BMC Cancer; 2011 Jan; 11():3. PubMed ID: 21205319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocellular carcinoma cells cause different responses in expressions of cancer-promoting genes in different cancer-associated fibroblasts.
    Lin ZY; Chuang WL
    Kaohsiung J Med Sci; 2013 Jun; 29(6):312-8. PubMed ID: 23684136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of EVA1A by miR-103a-3p promotes hepatocellular carcinoma cells proliferation and migration.
    Xu Q; Liao Z; Gong Z; Liu X; Yang Y; Wang Z; Yang W; Hou L; Yang J; Song J; Liu W; Wang B; Hua J; Pu M; Li N
    Cell Mol Biol Lett; 2022 Oct; 27(1):93. PubMed ID: 36273122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.